Dr. David Abram Zisman, MD, MS

Dr. Zisman practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Zisman's NPI, 1558381699, was assigned on July 20, 2006. Dr. Zisman graduated from Central University of Venezuela in 1991. Dr. Zisman holds Florida license ME154855.

Dr. Zisman's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Zisman's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Zisman is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Zisman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zisman practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Zisman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Zisman is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Zisman's licenses on file in 4 states: Florida, California, Pennsylvania and Michigan.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Zisman treats.

CMS data shows 1,148 Medicare services from Dr. Zisman across 12 procedure codes in 2024, for 426 Medicare patients. Medicare paid $74,743 for them.

CMS counts 426 Medicare patients who saw Dr. Zisman in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zisman's median patient age at 69, with 55% women.

In 2024, Dr. Zisman wrote 1,108 Medicare Part D claims for 203 patients. 45% of them were for generic drugs. CMS names the drug for 947 of them, across 24 drugs with 11 or more claims each, at $2,214,809 in total drug cost. In 2023, CMS named 806 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Zisman for performance year 2024, reported through an alternative payment model (APM). Dr. Zisman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zisman as offering telehealth.

Dmand AI links 19 papers to Dr. Zisman, published from 2002 to 2016. The most frequent topics are Lung Diseases, Interstitial, Pulmonary Fibrosis and Tumor Necrosis Factor-alpha. Dr. Zisman has published most often in Chest. Dr. Zisman's most frequent co-authors are Selim Mehmet Arcasoy, MD, Wan Chong Tsai, MD and John A. Belperio, MD.

Dmand AI links Dr. Zisman to 5 clinical trials, 3 of them phase 2 studies. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis. Rajan Saggar sponsors the most, 2. Open Payments lists research payments to Dr. Zisman that name 1 trial.

CMS Open Payments shows 667 general payments to Dr. Zisman from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Genentech, Inc. paid the most, $76,998. It also lists 2 research payments totaling $2,030 in 2024, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Zisman, most recently CMS Stage 1 EHR in 2013.

Dr. Zisman graduated from Central University of Venezuela in 1991. Dr. Zisman is a member of ACCP and SCCM.

Dr. Zisman is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.